TBCC (N-term), 20-49 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-TBCC (N-term), 20-49 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | TBCC (N-term), 20-49 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | mouse |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.36 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This TBCC antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 20-49 amino acids from the N-terminal region of human TBCC. Cofactor C is one of four proteins (cofactors A, D, E, andC) involved in the pathway leading to correctly folded beta-tubulinfrom folding intermediates. Cofactors A and D are believed to playa role in capturing and stabilizing beta-tubulin intermediates in aquasi-native confirmation. Cofactor E binds to the cofactorD/beta-tubulin complex; interaction with cofactor C then causes therelease of beta-tubulin polypeptides that are committed to thenative state. |
| Immunogen | n/a |
| Other Names | [Tubulin-specific chaperone C; Tubulin-folding cofactor C; CFC; TBCC] |
| Gene, Accession # | [TBCC], Gene ID: 6903, NCBI: NP_003183.1, UniProt: Q15814 |
| Catalog # | MBS9202609 |
| Price | $165, $370 |
| Order / More Info | TBCC (N-term), 20-49 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Hage-Sleiman, R., et al. BMC Cancer 10, 135 (2010) : Nature 447(7145):661-678(2007) Mungall, A.J., et al. Nature 425(6960):805-811(2003) Bartolini, F., et al. J. Biol. Chem. 277(17):14629-14634(2002) Tian, G., et al. Cell 86(2):287-296(1996) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies